Gene: MPZL3
Official Full Name: myelin protein zero like 3provided by HGNC
Gene Summary: Predicted to be involved in cell adhesion. Predicted to act upstream of or within extracellular matrix organization and hair cycle. Predicted to be located in membrane. Predicted to be active in plasma membrane. Implicated in lung cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16080 | MPZL3 Knockout cell line (HeLa) | Human | MPZL3 | 1:3~1:6 | Negative | Online Inquiry |
KO16081 | MPZL3 Knockout cell line (HCT 116) | Human | MPZL3 | 1:2~1:4 | Negative | Online Inquiry |
KO16082 | MPZL3 Knockout cell line (HEK293) | Human | MPZL3 | 1:3~1:6 | Negative | Online Inquiry |
KO16083 | MPZL3 Knockout cell line (A549) | Human | MPZL3 | 1:3~1:4 | Negative | Online Inquiry |
MPZL3 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to lack the expression of the MPZL3 gene, known for its involvement in various cellular processes, including cell adhesion and immune response regulation. These cell lines serve as invaluable tools for researchers aiming to dissect the biological role of MPZL3, revealing insights into its contributions to disease mechanisms, especially in contexts like neuroinflammation and cancer.
The primary function of MPZL3 Gene Knockout Cell Lines is to facilitate the study of gene function by providing a clean background to evaluate the effects of MPZL3 deletion. Researchers can use these models to investigate compensatory mechanisms, signaling pathways influenced by MPZL3, and the broader implications of its absence in cellular behavior, immune response, and tumor dynamics. By utilizing CRISPR-Cas9 technology or similar genome-editing tools, these cell lines ensure that the gene is precisely knocked out, allowing for reliable and reproducible experimental results.
From a scientific perspective, these cell lines hold critical importance in both basic and applied research settings. They can be instrumental in drug discovery processes, experimental therapeutics, and understanding pathophysiological conditions where MPZL3 is implicated. As cancer research advances, the ability to manipulate gene expression in cell models allows for tailored investigations into potential biomarkers and therapeutic targets.
One of the unique selling points of our MPZL3 Gene Knockout Cell Lines is their high specificity and efficiency, ensuring minimal off-target effects, compared to other knockout models that may also carry unwanted genetic alterations. Additionally, they are available in multiple cell backgrounds, accommodating diverse experimental designs that meet the needs of various research applications.
For researchers and clinicians striving to unlock the mysteries of gene function and disease mechanisms, MPZL3 Gene Knockout Cell Lines offer unparalleled value. Their reliability aids in the deduction of cause-and-effect relationships, ultimately driving forward innovative therapeutic avenues.
Our company, dedicated to advancing the frontiers of biological research, prides itself on providing high-quality, customized knockout models backed by robust scientific expertise. Our commitment ensures that you receive not only products but also the support needed to enhance your research outcomes effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.